MEI Pharma Inc (MEIP) — Cash Flow Reinvestment Rate

Latest as of December 2020: 1.27x

MEI Pharma Inc (MEIP) has a Cash Flow Reinvestment Rate of 1.27x as of December 2020, reinvesting $5.14 Million (capex $56.00K plus investments $-5.09 Million) from operating cash flow of $4.05 Million. Explore MEI Pharma Inc (MEIP) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.27x
(Capex + Investments) / Operating CF

Total Reinvested

$5.14 Million
Capex + Investments

Operating Cash Flow

$4.05 Million
USD

Capital Expenditures

$56.00K
USD

MEI Pharma Inc Cash Flow Reinvestment Rate (2017–2020)

Historical reinvestment intensity for MEI Pharma Inc across 2 annual periods. Also explore MEI Pharma Inc assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for MEI Pharma Inc (2017–2020)

Year-by-year capital reinvestment analysis for MEI Pharma Inc. For live market cap and broader valuation context, see MEI Pharma Inc stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 3.10x $106.29 Million $34.26 Million $894.00K ▲ +7.3%
2017 2.89x $10.08 Million $3.49 Million $51.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow